Tower Research Capital LLC (Trc) Celularity Inc Transaction History

Tower Research Capital LLC (Trc)

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$0.17 - $0.33 $3,806 - $7,389	-22,393 Reduced 44.14%	28,341 $7,000
Q3 2023 Nov 14, 2023	BUY	$0.22 - $0.56 $7,715 - $19,638	35,069 Added 223.87%	50,734 $11,000
Q2 2023 Aug 14, 2023	SELL	$0.42 - $0.81 $474 - $915	-1,130 Reduced 6.73%	15,665 $8,000
Q1 2023 May 09, 2023	SELL	$0.56 - $1.15 $257 - $527	-459 Reduced 2.66%	16,795 $10,000
Q4 2022 Feb 10, 2023	BUY	$1.08 - $2.35 $11,993 - $26,096	11,105 Added 180.6%	17,254 $22,000
Q3 2022 Nov 10, 2022	SELL	$0.43 - $4.31 $3,844 - $38,531	-8,940 Reduced 59.25%	6,149 $14,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $12.91 $34,251 - $157,359	12,189 Added 420.31%	15,089 $51,000
Q1 2022 May 12, 2022	BUY	$3.81 - $9.79 $11,049 - $28,390	2,900 New	2,900 $25,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.